SCHEMBL3175930

SCHEMBL3175930

CC(=O)NCCNc1cc(NC(=O)C(=O)N2CCC(C#N)(c3ccccc3)CC2)nc(-c2ccccc2)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRM4 P08173 1/20 0.40
▸ USP2 O75604 1/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ CLK4 Q9HAZ1 1/20 0.40
▸ DRD2 P14416 1/20 0.40
▸ DRD3 P35462 1/20 0.40
▸ ADORA2A P29274 3/20 0.39
▸ ADORA1 P30542 3/20 0.39
▸ F11 P03951 2/20 0.39
▸ ADRA1D P25100 4/20 0.38
▸ ADRA1A P35348 4/20 0.38
▸ ADRA1B P35368 3/20 0.38
▸ ADORA3 P0DMS8 2/20 0.38
▸ ADORA2B P29275 2/20 0.38
▸ CA12 O43570 2/20 0.38
▸ CA1 P00915 2/20 0.38
▸ CA2 P00918 2/20 0.38
▸ CA9 Q16790 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3172191 0.88 ADORA2A (0.41) USP2CYP1A2CYP3A4CYP2D6CLK4
SCHEMBL3162386 0.87 OPRD1 (0.46) CHRM4USP2CYP1A2CYP3A4CYP2D6
SCHEMBL3155892 0.85 ADORA2A (0.46) USP2CYP1A2CYP3A4CYP2D6CLK4
SCHEMBL3162937 0.85 ADORA2A (0.46) USP2CYP1A2CYP3A4CYP2D6CLK4
SCHEMBL3175769 0.84 ADORA2A (0.45) USP2CYP1A2CYP3A4CYP2D6CLK4
SCHEMBL3174594 0.84 ADORA2A (0.45) USP2CYP1A2CYP3A4CYP2D6CLK4
SCHEMBL3166225 0.84 ADORA2A (0.45) USP2CYP1A2CYP3A4CYP2D6CLK4
SCHEMBL3164900 0.83 ADORA2B (0.42) DRD2ADORA2AADORA1ADORA3ADORA2B
SCHEMBL3167608 0.82 ADORA2A (0.43) CYP1A2CYP3A4CYP2D6CLK4ADORA2A
SCHEMBL3165360 0.82 PHGDH (0.43) USP2CYP1A2CYP3A4CYP2D6CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 — — EP disclosed
Send feedback